A detailed history of Squarepoint Ops LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 336,184 shares of INVA stock, worth $6.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
336,184
Previous 134,019 150.85%
Holding current value
$6.44 Million
Previous $2.2 Million 195.31%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.33 - $20.04 $3.3 Million - $4.05 Million
202,165 Added 150.85%
336,184 $6.49 Million
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $1.93 Million - $2.2 Million
134,019 New
134,019 $2.2 Million
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $267,688 - $353,514
21,728 New
21,728 $348,000
Q4 2022

Feb 14, 2023

BUY
$11.8 - $13.78 $321,963 - $375,987
27,285 New
27,285 $361,000
Q2 2022

Aug 15, 2022

SELL
$14.32 - $19.88 $496,359 - $689,080
-34,662 Reduced 59.68%
23,417 $346,000
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $435,752 - $573,358
28,314 Added 95.13%
58,079 $1.12 Million
Q4 2021

Feb 14, 2022

BUY
$15.91 - $18.72 $298,582 - $351,318
18,767 Added 170.64%
29,765 $513,000
Q3 2021

Nov 15, 2021

SELL
$13.06 - $17.24 $231,240 - $305,251
-17,706 Reduced 61.68%
10,998 $184,000
Q2 2021

Aug 16, 2021

BUY
$11.45 - $13.96 $328,660 - $400,707
28,704 New
28,704 $385,000
Q1 2021

May 17, 2021

SELL
$11.06 - $12.87 $1.04 Million - $1.21 Million
-94,056 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$9.33 - $12.48 $323,555 - $432,793
34,679 Added 58.4%
94,056 $1.17 Million
Q3 2020

Nov 16, 2020

BUY
$10.33 - $14.49 $613,364 - $860,372
59,377 New
59,377 $620,000
Q2 2020

Aug 14, 2020

SELL
$11.49 - $15.26 $142,625 - $189,422
-12,413 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $513,719 - $964,729
-63,344 Reduced 83.61%
12,413 $146,000
Q4 2019

Feb 14, 2020

SELL
$10.28 - $14.38 $150,345 - $210,307
-14,625 Reduced 16.18%
75,757 $1.07 Million
Q3 2019

Nov 14, 2019

BUY
$10.05 - $14.55 $908,339 - $1.32 Million
90,382 New
90,382 $953,000
Q2 2019

Aug 14, 2019

SELL
$13.1 - $14.95 $1.34 Million - $1.53 Million
-102,093 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$13.69 - $20.06 $632,792 - $927,233
46,223 Added 82.73%
102,093 $1.43 Million
Q4 2018

Feb 14, 2019

BUY
$13.96 - $18.26 $779,945 - $1.02 Million
55,870 New
55,870 $975,000
Q3 2018

Nov 14, 2018

SELL
$13.63 - $15.7 $1.32 Million - $1.52 Million
-96,645 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$13.44 - $17.59 $1.24 Million - $1.62 Million
-91,931 Reduced 48.75%
96,645 $1.33 Million
Q1 2018

May 15, 2018

BUY
$13.8 - $16.99 $2.6 Million - $3.2 Million
188,576 New
188,576 $3.14 Million
Q4 2017

Feb 14, 2018

SELL
$11.73 - $14.75 $647,519 - $814,229
-55,202 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$12.06 - $14.12 $665,736 - $779,452
55,202
55,202 $779,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.